Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/11/16
End: 01/27/22
Due: 01/27/23
Phase: N/A
Priority: Normal
Start: 10/11/21
End: 09/30/23
Due: 09/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | NCT02581215 | Walid Shaib, MD | user2@example.com | None | 2016-09-11 | 2022-01-27 | 2023-01-27 | - | - | 2025-07-14 |
| Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma | NCT04895046 | Walid Shaib, MD | user2@example.com | None | 2021-10-11 | 2023-09-30 | 2024-09-30 | - | - | 2025-07-14 |